# Fibroscan Study in HCC

> **NCT01796145** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 207 (actual)

## Conditions studied

- Confirmed Diagnosis of Hepatocellular Carcinoma
- Patients Who Are Scheduled to Undergo Transarterial Chemobolization, Systemic Therapy Surgery
- Child's A to C Cirrhosis

## Interventions

- **OTHER:** Fibroscan

## Key facts

- **NCT ID:** NCT01796145
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-02-27
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01796145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01796145, "Fibroscan Study in HCC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01796145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*